Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sernova Corp is a clinical-stage regenerative medicine company developing the Cell Pouch System, an implantable device with immuno-protected cells designed to produce therapeutic proteins and hormones. The lead product targets type 1 diabetes by delivering continuous insulin production, aiming to reduce or eliminate insulin injection dependence. The platform has potential applications across multiple chronic debilitating disease indications.
investor_presentation
25 Pages
Sernova Corp 2022 Investor Presentation Cell Pouch
investor_presentationinvestor_presentation
26 Pages
investor_presentation
37 Pages
Enthusiast Gaming Holdings Inc.
investor_presentation
BC Iron